Platelet-activating factor and Escherichia coliO157:H7 infections.

Pediatr Nephrol

Division of Nephrology, Children's Hospital and Regional Medical Center, Department of Pediatrics, University of Washington, Seattle, Washington, USA.

Published: December 2002

The role of platelet-activating factor (PAF), a phospholipid inflammatory mediator, in Escherichia coli O157:H7-associated hemolytic uremic syndrome (HUS) is unknown. PAF is synthesized by diverse cells and is degraded by PAF-acetylhydrolase (PAF-AH). Deficient PAF-AH activity results from a G-->T transversion at position 994 of exon 9. We examined children infected with E. coliO157:H7 to determine if PAF levels or the PAF-AH ( G994T) mutation reflects the risk of developing HUS. Plasma PAF concentrations were determined using chloroform/methanol extraction, thin layer chromatography purification, and scintillation proximity assay in 10 patients with uncomplicated infection (UI), 10 infected patients who subsequently developed HUS (pre-HUS), 5 HUS patients, and 8 healthy controls. The PAF-AH ( G994T) allele frequency was determined in 52 UI children, 15 with HUS, and 11 controls. Wilcoxon rank sum tests were performed to test differences in location (median) of pairs of groups. PAF levels were higher in the UI ( P=0.04) and pre-HUS ( P=0.01) groups than in healthy controls. No subject had the PAF-AH ( G994T) allele. Thus, elevated plasma PAF levels occur in E. coliO157:H7-infected children, even without HUS, but diminish when HUS develops. The PAF-AH ( G994T) allele does not contribute to the risk of developing HUS.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00467-002-0970-7DOI Listing

Publication Analysis

Top Keywords

paf-ah g994t
16
paf levels
12
g994t allele
12
platelet-activating factor
8
hus
8
risk developing
8
developing hus
8
plasma paf
8
healthy controls
8
children hus
8

Similar Publications

Association of the G994T and R92H genotypes of platelet-activating factor acetylhydrolase with risk of preeclampsia in Chinese women.

Pregnancy Hypertens

April 2020

Laboratory of Genetic Disease and Perinatal Medicine, Key Laboratory of Birth Defects and Related Diseases of Women and Children, Ministry of Education, West China Second University Hospital, Sichuan University, 610041, Chengdu, Sichuan, People's Republic of China. Electronic address:

Article Synopsis
  • The study aimed to explore the link between the PLA2G7 gene polymorphisms (G994T and R92H) and the risk of developing preeclampsia (PE) in Chinese women, using a case-control design involving 273 PE patients and 530 healthy pregnant women.
  • Significant findings showed that the G994T polymorphism was more common in PE patients, with the GT + TT genotype associated with a higher risk for PE even after adjusting for factors like age and BMI (odds ratio = 4.926).
  • The study concluded that the G994T polymorphism increases the risk of preeclampsia, while the R92H polymorphism had no significant association.
View Article and Find Full Text PDF

Effect of the R92H and A379V genotypes of platelet-activating factor acetylhydrolase on its enzyme activity, oxidative stress and metabolic profile in Chinese women with polycystic ovary syndrome.

Lipids Health Dis

March 2017

Laboratory of Genetic Disease and Perinatal Medicine, Key Laboratory of Birth Defects and Related Diseases of Women and Children, Ministry of Education, West China Second University Hospital, Sichuan University, Chengdu, Sichuan, 610041, People's Republic of China.

Background: The G994T polymorphism in platelet-activating factor acetylhydrolase (PAF-AH) gene is associated with the risk of polycystic ovary syndrome (PCOS). The aim of this study was to investigate the relationship between R92H and A379V variants of the PAF-AH gene and the risk of PCOS and to evaluate the effects of the genotypes on PAF-AH activities and clinical, metabolic and oxidative stress indexes in Chinese women.

Methods: A total of 862 patients with PCOS based on the Rotterdam consensus criteria and 750 control women from a population of Chinese Han nationality in the Chengdu area were studied from 2006-2015.

View Article and Find Full Text PDF

Naturally Occurring Missense Mutation in Plasma PAF-AH Among the Japanese Population.

Enzymes

January 2015

Faculty of Pharmaceutical Sciences, Teikyo University, Tokyo, Japan. Electronic address:

A single nucleotide polymorphism in the plasma PAF-AH enzyme, i.e., G994T, which causes the substitution of Val at amino acid 279 with Phe (V279F), has been found in the Japanese population.

View Article and Find Full Text PDF

Identification of the G994T polymorphism in exon 9 of plasma platelet-activating factor acetylhydrolase gene as a risk factor for polycystic ovary syndrome.

Hum Reprod

May 2010

Laboratory of Genetic Disease and Perinatal Medicine, West China Second University Hospital, Sichuan University, Chengdu 610041, Sichuan, People's Republic of China.

Background: Low-grade chronic inflammation and greater risks of cardiovascular diseases are often present in patients with polycystic ovary syndrome (PCOS). Platelet-activating factor (PAF) acetylhydrolase (PAF-AH) hydrolyzes and inactivates PAF and PAF-like oxidized phospholipids that are potent lipid mediators involved in inflammation and atherosclerosis. Deficiency of this enzyme is caused by a missense mutation (G994 --> T) in exon 9 of the plasma PAF-AH gene.

View Article and Find Full Text PDF

Objective: Platelet-activating factor (PAF) is a phospholipid with multiple actions that is involved in inflammatory diseases as well as in atherogenesis. It is inactivated by a plasma enzyme, PAF-acetylhydrolase (PAF-AH). Deficiency of this enzyme in plasma is caused by a missense mutation in the gene (G994T).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!